Serum fibrosis biomarkers predict death and graft loss in liver transplantation recipients.

about

Performance of transient elastography and serum fibrosis biomarkers for non-invasive evaluation of recurrent fibrosis after liver transplantation: A meta-analysis.Oval Cells Contribute to Fibrogenesis of Marginal Liver Grafts under Stepwise Regulation of Aldose Reductase and Notch Signaling.

P2860

Q42365178-4F1EF5FE-9484-4569-925D-7B1600789A28 Q47099031-8A7D0A88-02DD-4593-AB5D-A865858FDCC6

P2860

Serum fibrosis biomarkers predict death and graft loss in liver transplantation recipients.

Item

http://www.wikidata.org/entity/Q41565564

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Serum fibrosis biomarkers pred ...... er transplantation recipients.

@en

type

Item

label

Serum fibrosis biomarkers pred ...... er transplantation recipients.

@en

prefLabel

Serum fibrosis biomarkers pred ...... er transplantation recipients.

@en

P1476

Serum fibrosis biomarkers pred ...... ver transplantation recipients

@en

P2093

Aparna Bhat

http://www.w3.org/2001/XMLSchema#string

Kathleen C Rollet-Kurhajec

http://www.w3.org/2001/XMLSchema#string

Mamatha Bhat

http://www.w3.org/2001/XMLSchema#string

Marc Deschenes

http://www.w3.org/2001/XMLSchema#string

Peter Ghali

http://www.w3.org/2001/XMLSchema#string

Philip Wong

http://www.w3.org/2001/XMLSchema#string

P2860

Ultrasound-based transient elastography for the detection of hepatic fibrosis in patients with recurrent hepatitis C virus after liver transplantation: a systematic review and meta-analysis

Physicians' practices for diagnosing liver fibrosis in chronic liver diseases: a nationwide, Canadian survey.

Change in platelet count in patients with hypersplenism subjected to liver transplantation.

Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus.

The metabolic effects of cyclosporin and tacrolimus.

Non-invasive assessment of liver fibrosis in chronic liver diseases: implementation in clinical practice and decisional algorithms.

Simple noninvasive systems predict long-term outcomes of patients with nonalcoholic fatty liver disease

Noninvasive tests for evaluation of fibrosis in HCV recurrence after liver transplantation: a systematic review.

Evolution of nonalcoholic fatty liver disease recurrence after liver transplantation.

FibroScan (vibration-controlled transient elastography): where does it stand in the United States practice.

P304

1383-1394

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/LT.24217

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Giada Sebastiani

P577

2015-10-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26194602

http://www.w3.org/2001/XMLSchema#string

P921

liver transplantation

biomarker

Serum fibrosis biomarkers predict death and graft loss in liver transplantation recipients.

about

P2860

P2860

Serum fibrosis biomarkers predict death and graft loss in liver transplantation recipients.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921